THERAPEUTIC BINDING MOLECULES

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250084174A1
SERIAL NO

18787823

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIMMUNE LIMITED1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE CB2 0AA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CARIUK, Peter Cambridge, GB 7 0
HUNTINGTON, Catherine Cambridge, GB 4 11
IRVING, Lorraine Cambridge, GB 7 0
NYS, Josquin Cambridge, GB 2 0
REES, David Cambridge, GB 25 186
RILEY, Aidan Cambridge, GB 3 0
ROBINSON, Matthew Cambridge, GB 32 354
SCHOFIELD, Darren Cambridge, GB 20 14
THOM, Albert Cambridge, GB 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation